Beijing, China

Zi Ye

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Chinese Academy of Medical Sciences. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zi Ye. Retrieved from https://idiyas.com/inventor/zi-ye-rt4t79v6

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Inventor Zi Ye

Introduction

Zi Ye is a prominent inventor based in Beijing, China. He has made significant contributions to the field of medical technology, particularly in the development of functional small molecules that target proteolysis pathways. His work is crucial in the advancement of tumor-treating drugs.

Latest Patents

Zi Ye holds a patent for a class of functional molecules targeting proteolysis pathways, which includes the preparation and application of these molecules. The invention focuses on small molecules that can bind to multiple proteins involved in the proteolysis pathway, demonstrating anti-tumor biological activity. This innovative approach is represented by a specific formula and includes pharmaceutically acceptable salts.

Career Highlights

Zi Ye is affiliated with the Chinese Academy of Medical Sciences, where he conducts his research and development. His work has garnered attention for its potential impact on cancer treatment and therapeutic applications.

Collaborations

Zi Ye collaborates with notable colleagues, including Chongjing Zhang and Fujia Wang, to further enhance the research and application of his inventions.

Conclusion

Zi Ye's contributions to medical technology through his innovative patents highlight the importance of research in developing effective treatments for tumors. His work continues to pave the way for advancements in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…